Scientists launch major study to unravel rare genetic conditions
NCT ID NCT04888936
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study aims to learn more about RASopathies, a group of genetic conditions that can cause developmental issues, birth defects, and increased cancer risk. Researchers will follow up to 500 people of any age who have or may have a RASopathy, along with their family members, for an indefinite period. Participants will provide medical history, blood, urine, and saliva samples, and may undergo various exams and scans to track health changes over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAPILLARY ARTERIOVENOUS MALFORMATION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute - Shady Grove
RECRUITINGRockville, Maryland, 20850, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists dive into cells to unravel costello Syndrome's secrets
- New drug aims to help kids with rare genetic short stature grow taller
- Noonan syndrome study aims to uncover hidden heart risks
- Noonan syndrome research: scientists launch sample collection to unlock disease secrets
- New drug aims to boost growth in kids with noonan syndrome
- New program aims to ease burden on families of kids with rare diseases